Prestige Consumer Healthcare (PBH) Gross Margin Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Gross Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 93.00 |
| Sep 30, 2025 | -36.00 |
| Jun 30, 2025 | -155.00 |
| Mar 31, 2025 | 157.00 |
| Dec 31, 2024 | -102.00 |
| Sep 30, 2024 | -164.00 |
| Jun 30, 2024 | -441.00 |
| Mar 31, 2024 | -284.00 |
| Dec 31, 2023 | -230.00 |
| Sep 30, 2023 | -209.00 |
| Jun 30, 2023 | -298.00 |
| Mar 31, 2023 | -349.00 |
| Dec 31, 2022 | -233.00 |
| Sep 30, 2022 | -178.00 |
| Jun 30, 2022 | 4.00 |
| Mar 31, 2022 | -159.00 |
| Dec 31, 2021 | -118.00 |
| Sep 30, 2021 | -34.00 |
| Jun 30, 2021 | 370.00 |
| Mar 31, 2021 | 246.00 |